Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP)

Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP)

<i>Background and Objectives</i>: eBEACOPP is the most effective chemotherapy regimen for younger patients with early unfavorable (EU) and advanced-stage (AS) Hodgkin lymphoma (HL), albeit with significant toxicities. The 14-day/cycle prednisone course contributes to side effects, includ...

Full description

Bibliographic Details
Main Authors: Ida Hude Dragičević, Sandra Bašić-Kinda, Helena Markotić, Martina Morić-Perić, Dino Dujmović, Ivo Radman, Barbara Dreta, Snježana Dotlić, Ivana Ilić, Lea Galunić Bilić, Margareta Dobrenić, Marko Kralik, Igor Aurer
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Medicina
Subjects:
Hodgkin lymphoma
eBEACOPP
corticosteroids
toxicity
avascular hip necrosis
Online Access:https://www.mdpi.com/1648-9144/60/3/430

Internet

https://www.mdpi.com/1648-9144/60/3/430

Similar Items